Li B, Qi F, Zhu F, Lu Z, et al. Nanoparticle-based combination therapy enhances fulvestrant efficacy and overcomes tumor resistance in ER-positive breast cancer. Cancer Res 2023 Jun 16:CAN-22-3559. doi: 10.1158/0008-5472.CAN-22-3559.
PMID: 37326467